These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 4242324)

  • 1. [Achievement and clinical study of preparation plasmin, activated by urokinase].
    Stasiuk NS
    Probl Gematol Pereliv Krovi; 1967 Sep; 12(9):37-9. PubMed ID: 4242324
    [No Abstract]   [Full Text] [Related]  

  • 2. Urokinase evaluated with the experimental radioactive embolus.
    Hume M
    Thromb Diath Haemorrh; 1967 May; 17(3-4):405-11. PubMed ID: 4231948
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on hyaine membrane disease.3. Thrapeutic trial of urokinase-activated huma plasmin.
    Ambrus CM; Weintrb DH; Ambrus JL
    Pediatrics; 1966 Aug; 38(2):231-43. PubMed ID: 4223366
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical and laboratory experiences with selective thrombolysis.
    Bookstein JJ
    Ann Radiol (Paris); 1984; 27(4):322-3. PubMed ID: 6234843
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thrombolytic treatment of thromboembolytic conditions].
    Gormsen J
    Ugeskr Laeger; 1966 Oct; 128(42):1235-45. PubMed ID: 4231392
    [No Abstract]   [Full Text] [Related]  

  • 6. [Expediency of the use of uroplasmin in clinical practice].
    Skipetrov VP; Potapkina N; Chernyshev V; Shuvalov V
    Vrach Delo; 1974 Jan; (1):48-50. PubMed ID: 4283231
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental thrombolysis by perfusion. II. Comparative study on the effect of streptokinase, urokinase and plasmin.
    Egeblad K; Bertelsen S
    Acta Chir Scand; 1969; 135(6):486-90. PubMed ID: 4244115
    [No Abstract]   [Full Text] [Related]  

  • 8. [Plasminogen and plasmin determination in human plasma].
    Bruhn HD; Müller L; Duckert F
    Schweiz Med Wochenschr; 1968 Oct; 98(42):1650. PubMed ID: 4235242
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical substantiation of the expediency of using the euglobulin fractions of blood plasma from persons who died suddenly for obtaining the preparations of fibrinolytic action].
    Khvatov VB; Platonova TK
    Probl Gematol Pereliv Krovi; 1976 Mar; 21(3):38-42. PubMed ID: 136655
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of thromboobliterative diseases of vessles with a fibrinolysin preparation in combination with anticoagulants].
    Dekhtiar' AL; Synovets AS
    Klin Med (Mosk); 1967 Jan; 45(1):88-91. PubMed ID: 4235406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolysin therapy of thromboembolism of the major vessles].
    Kal'chenko II; Lys PV
    Vrach Delo; 1967; 7():60-4. PubMed ID: 4246661
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of thromboembolism of the aortic bifurcation with fibrinolysin and heparin].
    Mel'nik PA; Gudz SG
    Vrach Delo; 1966 Oct; 10():144-5. PubMed ID: 4231520
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolysis of tissue factor pathway inhibitor (TFPI) by plasmin: effect on TFPI activity.
    Li A; Wun TC
    Thromb Haemost; 1998 Sep; 80(3):423-7. PubMed ID: 9759622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinolytic and defibrinogenation therapy].
    Mannucci PM; Mari D
    Ric Clin Lab; 1983; 13 Suppl 3():245-55. PubMed ID: 6672998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fibrinolysin therapy of thromboembolization of the abdominal aorta in the region of bifurcation].
    Klets RL
    Sov Med; 1965 Nov; 28(11):98-101. PubMed ID: 4225152
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of fibrinolysin (plasmin) in thromboembolic diseases].
    MACIAS CASTRO I
    Arch Hosp Univ; 1958; 10(6):463-6. PubMed ID: 13628412
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants.
    Gandorfer A; Ulbig M; Kampik A
    Eye (Lond); 2002 Jan; 16(1):95-7. PubMed ID: 11913902
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasmin potency estimates: influence of the substrate used in assay.
    Philo RD; Gaffney PJ
    Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.